Unlocking Opportunities in the Companion Diagnostics Market: Key Growth Trends and Forecast Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Growth Potential of the Companion Diagnostics Market, and How Will It Perform by 2034?
In recent years, the market size for companion diagnostics has expanded at an impressive rate. With a projected and rapid growth from $7.34 billion in 2024 to $8.75 billion in 2025, the compound annual growth rate (CAGR) stands at 19.3%. This considerable growth during the past years is largely due to the rising adoption of personalized medicine, the proliferation of cancer therapies and oncology, escalated collaborations in pharmaceutical research and development, a drive towards precision medicine and the discovery of biomarkers.
In the forthcoming years, there will be significant surge in the size of the companion diagnostics market. It is predicted to expand to an impressive $19.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 21.5%. This projected growth in the forecast period is due to factors like developments in targetedTherapy, diagnostics for infectious and rare diseases, enhancement in biomarker-based drug development, point-of-care testing, and applications of liquid biopsy. The future trends include advancements in immunotherapy and immunology, the incorporation of artificial intelligence and machine learning in diagnostics, innovative products, the implementation of industry 4.0, and strategic alliances.
Which Major Market Drivers Are Expected to Boost the companion diagnostics Market’s Growth Potential?
The expansion of the companion diagnostics market is anticipated to be fueled by the growing number of targeted therapies. This type of pharmacological remedy specifically focuses on distinct characteristics of cancer cells to restrict their development and dispersion. These medications travel across the body but offer a more specified effect compared to chemotherapy, often with lesser side effects. Tests for companion diagnostics using bio-markers for targeted cancer treatment are becoming a crucial component of tailored cancer care. To exemplify, the Personalised Medicine Coalition, a U.S.-based healthcare and hospital organization, reported in February 2024 that the FDA sanctioned 16 new individualized treatments for patients with rare diseases in 2023, an increase from six in 2022. As a consequence, the boom in targeted therapies is stimulating the development of the companion diagnostics market.
Request Your Free Companion Diagnostics Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7038&type=smp
Who Are the Major Companies Shaping the Competitive Landscape of the Companion Diagnostics Market?
Major companies operating in the companion diagnostics market include:
• F Hoffmann-La Roche Ltd._x000D_
• Agilent Technologies Inc._x000D_
• Qiagen NV_x000D_
• Thermo Fisher Scientific Inc._x000D_
• Abbott Laboratories Inc._x000D_
What Are the Key Emerging Trends in the Companion Diagnostics Market for the Next Decade?
A leading trend in the companion diagnostics market is the progression of technology. The application of artificial intelligence aids in the creation of more effective drugs for companion diagnostics. The broad usage of AI has been facilitated by the impressive amount of data consistently generated from diverse genetic profiling. For instance, Deep Genomics, a startup based in Toronto, employs artificial intelligence to identify improved treatments for genetic diseases and expedite their integration into clinical trials. The objective is to utilize deep learning to traverse the human genome to locate information about disease causes and design and examine chemical compounds that might serve as solutions. Deep learning in a computational model allows researchers to scrutinize billions of chemical compounds to find promising preparations that can be transformed into life-saving medicines for individuals around the globe.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report
What Are the Major Segments of the Companion Diagnostics Market and Their Role in Driving Growth?
The companion diagnostics market covered in this report is segmented –
1) By Product And Service: Assays, Kits And Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Next-Generation Sequencing, In Situ Hybridization, Immunohistochemistry
3) By Indication: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations
Subsegments:
1) By Assays: Polymerase Chain Reaction (PCR) Assays, Immunohistochemistry (IHC) Assays, Next-Generation Sequencing (NGS) Assays, In Situ Hybridization (ISH) Assays
2) By Kits And Reagents: Diagnostic Kits, Detection Reagents, Control Reagents
3) By Software And Services: Data Analysis Software, Interpretation Software, Custom Development Services, Consulting and Support Services
Which Regions Are Making a Mark in the Companion Diagnostics Market Growth?
North America was the largest region in the companion diagnostics market in 2024. The regions covered in the companion diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Companion Diagnostics Market Categorized and Defined in the Industry?
Companion diagnostics is an in vitro diagnostic medical test used to check the safety and effectivity of a corresponding drug or biological product. The test aids a medical expert to match a patient to a specific drug or therapy.
Browse Through More Similar Reports By The Business Research Company:
Interventional Oncology Devices Global Market Report 2024
Oncology Biosimilars Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-biosimilar-global-market-report
Oncology Molecular Diagnostics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
